Table 1 Patient, disease and treatment characteristics

Patients, N (%)

77

Age (years), median (min–max)

70 (24–89)

Sex: female:male, N (%)

50 (64.9):27 (35.1)

Charlson comorbidity index

 1–3

32 (41.5)

 4–6

30 (39)

 7–10

15 (19.5)

Disease characteristics

 Bleeding as first symptom of disease

32 (41.6)

 Recurrent disease, N (%)

22 (28.2)

Treatment characteristics

 Dose, median (min–max)

39.0 Gy (9–84.4)

 Chemotherapy, prior to acute bleeding symptomatic (N (%))

30 (39.0)

 Immunotherapy, any (N (%))

2 (2.6)